MicroRNAs in epilepsy: pathophysiology and clinical utility

The Lancet Neurology

Volumn 15, Issue 13, 2016, Pages 1368-1376

  Henshall, David C ^a   Hamer, Hajo M ^b   Pasterkamp, R Jeroen ^c   Goldstein, David B ^d   Kjems, Jørgen ^e   Prehn, Jochen H M ^a   Schorge, Stephanie ^f   Lamottke, Kai ^g   Rosenow, Felix ^h,i  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d Columbia University ^*  (United States)

^e AARHUS UNIVERSITY   (Denmark)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g Bicoll GmbH   (Germany)

^h GOETHE UNIVERSITY   (Germany)

ⁱ PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTAGOMIR; ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; DNA; MICRORNA; NANOPARTICLE; NEUROTRANSMITTER; PILOCARPINE; TRANSCRIPTION FACTOR;

ANTISENSE THERAPY; BRAIN; BRAIN INJURY; CELLS BY BODY ANATOMY; CEREBROSPINAL FLUID; CLINICAL PRACTICE; DIAGNOSTIC TEST; DNA METHYLATION; DRUG FORMULATION; EPILEPSY; EPILEPTIC STATE; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE TARGETING; GENETIC VARIATION; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; NERVE CELL CULTURE; NERVOUS SYSTEM INFLAMMATION; NERVOUS TISSUE; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RNA INTERFERENCE; SEIZURE; SHORT SURVEY; TEMPORAL LOBE EPILEPSY; ANIMAL; METABOLISM;

ANIMALS; EPILEPSY; HUMANS; MICRORNAS;

EID: 84994410160     PISSN: 14744422     EISSN: 14744465     Source Type: Journal    
DOI: 10.1016/S1474-4422(16)30246-0     Document Type: Short Survey

References (75)

1. 1 WHO Executive Board. Global burden of epilepsy and the need for coordinated action at the country level to address its health, social and public knowledge implications. Report by the Secretariat. EB136/13. Dec 12, 2015.
2. 2 Baulac, M, de Boer, H, Elger, C, et al. Epilepsy priorities in Europe: a report of the ILAE-IBE Epilepsy Advocacy Europe Task Force. Epilepsia 56 (2015), 1687–1695.
3. 3 Olesen, J, Gustavsson, A, Svensson, M, Wittchen, HU, Jonsson, B, The economic cost of brain disorders in Europe. Eur J Neurol 19 (2012), 155–162.
4. 4 Pitkanen, A, Loscher, W, Vezzani, A, et al. Advances in the development of biomarkers for epilepsy. Lancet Neurol 15 (2016), 843–856.
5. 5 Loscher, W, Klitgaard, H, Twyman, RE, Schmidt, D, New avenues for antiepileptic drug discovery and development. Nat Rev Drug Discov 12 (2013), 757–776.
6. 6 Johnson, MR, Behmoaras, J, Bottolo, L, et al. Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus. Nat Commun, 6, 2015, 6031.
7. 7 Lagos-Quintana, M, Rauhut, R, Lendeckel, W, Tuschl, T, Identification of novel genes coding for small expressed RNAs. Science 294 (2001), 853–858.
8. 8 Friedman, RC, Farh, KK, Burge, CB, Bartel, DP, Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19 (2009), 92–105.
9. 9 Chandradoss, SD, Schirle, NT, Szczepaniak, M, MacRae, IJ, Joo, C, A dynamic search process underlies microRNA targeting. Cell 162 (2015), 96–107.
10. 10 O'Carroll, D, Schaefer, A, General principals of miRNA biogenesis and regulation in the brain. Neuropsychopharmacology 38 (2013), 39–54.
11. 11 Lin, S, Gregory, RI, MicroRNA biogenesis pathways in cancer. Nat Rev Cancer 15 (2015), 321–333.
12. 12 Ebert, MS, Sharp, PA, Roles for microRNAs in conferring robustness to biological processes. Cell 149 (2012), 515–524.
13. 13 Tan, CL, Plotkin, JL, Veno, MT, et al. MicroRNA-128 governs neuronal excitability and motor behavior in mice. Science 342 (2013), 1254–1258.
14. 14 Mooney, C, Becker, BA, Raoof, R, Henshall, DC, EpimiRBase: a comprehensive database of microRNA-epilepsy associations. Bioinformatics 32 (2016), 1436–1438.
15. 15 Fromm, B, Billipp, T, Peck, LE, et al. A uniform system for the annotation of vertebrate microRNA genes and the evolution of the human microRNAome. Annu Rev Genet 49 (2015), 213–242.
16. 16 Wang, X, Sun, Y, Tan, Z, et al. Serum microRNA-4521 is a potential biomarker for focal cortical dysplasia with refractory epilepsy. Neurochem Res 41 (2016), 905–912.
17. 17 Aronica, E, Fluiter, K, Iyer, A, et al. Expression pattern of miR-146a, an inflammation-associated microRNA, in experimental and human temporal lobe epilepsy. Eur J Neurosci 31 (2010), 1100–1107.
18. 18 Kan, AA, van Erp, S, Derijck, AA, et al. Genome-wide microRNA profiling of human temporal lobe epilepsy identifies modulators of the immune response. Cell Mol Life Sci 69 (2012), 3127–3145.
19. 19 McKiernan, RC, Jimenez-Mateos, EM, Bray, I, et al. Reduced mature microRNA levels in association with Dicer loss in human temporal lobe epilepsy with hippocampal sclerosis. PLoS One, 7, 2012, e35921.
20. 20 Jimenez-Mateos, EM, Bray, I, Sanz-Rodriguez, A, et al. miRNA Expression profile after status epilepticus and hippocampal neuroprotection by targeting miR-132. Am J Pathol 179 (2011), 2519–2532.
21. 21 Sano, T, Reynolds, JP, Jimenez-Mateos, EM, Matsushima, S, Taki, W, Henshall, DC, MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis, 3, 2012, e287.
22. 22 Hu, K, Xie, YY, Zhang, C, et al. MicroRNA expression profile of the hippocampus in a rat model of temporal lobe epilepsy and miR-34a-targeted neuroprotection against hippocampal neurone cell apoptosis post-status epilepticus. BMC Neurosci, 13, 2012, 115.
23. 23 Jimenez-Mateos, EM, Engel, T, Merino-Serrais, P, et al. Silencing microRNA-134 produces neuroprotective and prolonged seizure-suppressive effects. Nat Med 18 (2012), 1087–1094.
24. 24 McKiernan, RC, Jimenez-Mateos, EM, Sano, T, et al. Expression profiling the microRNA response to epileptic preconditioning identifies miR-184 as a modulator of seizure-induced neuronal death. Exp Neurol 237 (2012), 346–354.
25. 25 Jimenez-Mateos, EM, Engel, T, Merino-Serrais, P, et al. Antagomirs targeting microRNA-134 increase hippocampal pyramidal neuron spine volume in vivo and protect against pilocarpine-induced status epilepticus. Brain Struct Func 220 (2015), 2387–2399.
26. 26 Ren, L, Zhu, R, Li, X, Silencing miR-181a produces neuroprotection against hippocampus neuron cell apoptosis post-status epilepticus in a rat model and in children with temporal lobe epilepsy. Genet Mol Res, 15, 2016, 15017798.
27. 27 Wang, D, Li, Z, Zhang, Y, et al. Targeting of microRNA-199a-5p protects against pilocarpine-induced status epilepticus and seizure damage via SIRT1-p53 cascade. Epilepsia 57 (2016), 706–716.
28. 28 Chen, L, Zheng, H, Zhang, S, Involvement of upregulation of miR-210 in a rat epilepsy model. Neuropsych Dis Treat 12 (2016), 1731–1737.
29. 29 Lee, ST, Jeon, D, Chu, K, et al. Inhibition of miR-203 reduces spontaneous recurrent seizures in mice. Mol Neurobiol, 2016, 10.1007/s12035-016-9901-7 published online May 10.
30. 30 Jimenez-Mateos, EM, Arribas-Blazquez, M, Sanz-Rodriguez, A, et al. MicroRNA targeting of the P2X7 purinoceptor opposes a contralateral epileptogenic focus in the hippocampus. Sci Rep, 5, 2015, e17486.
31. 31 Zheng, H, Tang, R, Yao, Y, et al. MiR-219 protects against seizure in the kainic acid model of epilepsy. Mol Neurobiol 53 (2016), 1–7.
32. 32 Zhan, L, Yao, Y, Fu, H, et al. Protective role of miR-23b-3p in kainic acid-induced seizure. Neuroreport 27 (2016), 764–768.
33. 33 Wang, W, Wang, X, Chen, L, et al. The microRNA miR-124 suppresses seizure activity and regulates CREB1 activity. Exp Rev Mol Med, 18, 2016, e4.
34. 34 Brennan, GP, Dey, D, Chen, Y, et al. Dual and opposing roles of microRNA-124 in epilepsy are mediated through inflammatory and NRSF-dependent gene networks. Cell Rep 14 (2016), 2402–2412.
35. 35 Cai, Z, Li, S, Li, S, et al. Antagonist targeting microRNA-155 protects against lithium-pilocarpine-induced status epilepticus in C57BL/6 mice by activating brain-derived neurotrophic factor. Front Pharmacol, 7, 2016, 129.
36. 36 Fiumara, F, Rajasethupathy, P, Antonov, I, Kosmidis, S, Sossin, WS, Kandel, ER, MicroRNA-22 gates long-term heterosynaptic plasticity in Aplysia through presynaptic regulation of CPEB and downstream targets. Cell Rep 11 (2015), 1866–1875.
37. 37 Butovsky, O, Jedrychowski, MP, Cialic, R, et al. Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice. Ann Neurol 77 (2015), 75–99.
38. 38 Huang, Y, Liu, X, Liao, Y, et al. MiR-181a influences the cognitive function of epileptic rats induced by pentylenetetrazol. Int J Clin Exp Pathol 8 (2015), 12861–12868.
39. 39 Saba, R, Storchel, PH, Aksoy-Aksel, A, et al. Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons. Mol Cell Biol 32 (2012), 619–632.
40. 40 Tsujimura, K, Irie, K, Nakashima, H, et al. miR-199a links MeCP2 with mTOR signaling and its dysregulation leads to Rett syndrome phenotypes. Cell Rep 12 (2015), 1887–1901.
41. 41 Crino, PB, The mTOR signalling cascade: paving new roads to cure neurological disease. Nat Rev Neurol 12 (2016), 379–392.
42. 42 Santa-Maria, I, Alaniz, ME, Renwick, N, et al. Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau. J Clin Invest 125 (2015), 681–686.
43. 43 Iyer, A, Zurolo, E, Prabowo, A, et al. MicroRNA-146a: a key regulator of astrocyte-mediated inflammatory response. PLoS One, 7, 2012, e44789.
44. 44 Kaalund, SS, Veno, MT, Bak, M, et al. Aberrant expression of miR-218 and miR-204 in human mesial temporal lobe epilepsy and hippocampal sclerosis-convergence on axonal guidance. Epilepsia 55 (2014), 2017–2027.
45. 45 Roncon, P, Soukupova, M, Binaschi, A, et al. MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy—comparison with human epileptic samples. Sci Rep, 5, 2015, 14143.
46. 46 Van Battum, EY, Brignani, S, Pasterkamp, RJ, Axon guidance proteins in neurological disorders. Lancet Neurol 14 (2015), 532–546.
47. 47 Jessberger, S, Parent, JM, Epilepsy and adult neurogenesis. Cold Spring Harb Perspect Biol, 7, 2015, a020677.
48. 48 Dombkowski, AA, Batista, CE, Cukovic, D, et al. Cortical tubers: windows into dysregulation of epilepsy risk and synaptic signaling genes by microRNAs. Cereb Cortex 26 (2016), 1059–1071.
49. 49 He, M, Liu, Y, Wang, X, Zhang, MQ, Hannon, GJ, Huang, ZJ, Cell-type-based analysis of microRNA profiles in the mouse brain. Neuron 73 (2012), 35–48.
50. 50 Amin, ND, Bai, G, Klug, JR, et al. Loss of motoneuron-specific microRNA-218 causes systemic neuromuscular failure. Science 350 (2015), 1525–1529.
51. 51 Miller-Delaney, SF, Bryan, K, Das, S, et al. Differential DNA methylation profiles of coding and non-coding genes define hippocampal sclerosis in human temporal lobe epilepsy. Brain 138 (2015), 616–631.
52. 52 Cui, L, Tao, H, Wang, Y, et al. A functional polymorphism of the microRNA-146a gene is associated with susceptibility to drug-resistant epilepsy and seizures frequency. Seizure 27 (2015), 60–65.
53. 53 Li, T, Kuang, Y, Li, B, The genetic variants in 3′ untranslated region of voltage-gated sodium channel alpha 1 subunit gene affect the mRNA-microRNA interactions and associate with epilepsy. BMC Genet, 17, 2016, 111.
54. 54 Manna, I, Labate, A, Borzi, G, et al. An SNP site in pri-miR-124, a brain expressed miRNA gene, no contribution to mesial temporal lobe epilepsy in an Italian sample. Neurol Sci 37 (2016), 1335–1339.
55. 55 Panjwani, N, Wilson, MD, Addis, L, et al. A microRNA-328 binding site in PAX6 is associated with centrotemporal spikes of rolandic epilepsy. Ann Clin Trans Neurol 3 (2016), 512–522.
56. 56 Kozomara, A, Griffiths-Jones, S, miRBase: annotating high confidence microRNAs using deep sequencing data. Nucl Acid Res 42 (2014), D68–D73.
57. 57 Ziats, MN, Rennert, OM, Identification of differentially expressed microRNAs across the developing human brain. Mol Psychiatry 19 (2014), 848–852.
58. 58 Chou, CH, Chang, NW, Shrestha, S, et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucl Acid Res 44 (2016), D239–D247.
59. 59 Turchinovich, A, Weiz, L, Burwinkel, B, Extracellular miRNAs: the mystery of their origin and function. Trends Biochem Sci 37 (2012), 460–465.
60. 60 Liu, DZ, Tian, Y, Ander, BP, et al. Brain and blood microRNA expression profiling of ischemic stroke, intracerebral hemorrhage, and kainate seizures. J Cereb Blood Flow Metab 30 (2010), 92–101.
61. 61 Wang, J, Yu, JT, Tan, L, et al. Genome-wide circulating microRNA expression profiling indicates biomarkers for epilepsy. Sci Rep, 5, 2015, 9522.
62. 62 Wang, J, Tan, L, Tan, L, et al. Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy. Sci Rep, 5, 2015, 10201.
63. 63 Spain, E, Jimenez-Mateos, EM, Raoof, R, et al. Direct, non-amplified detection of microRNA-134 in plasma from epilepsy patients. RSC Advances 5 (2015), 90071–90078.
64. 64 Lidster, K, Jefferys, JG, Blumcke, I, et al. Opportunities for improving animal welfare in rodent models of epilepsy and seizures. J Neurosci Methods 260 (2016), 2–25.
65. 65 Ledri, LN, Melin, E, Christiansen, SH, et al. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors. Neurobiol Dis 86 (2016), 52–61.
66. 66 Galanopoulou, AS, Buckmaster, PS, Staley, KJ, et al. Identification of new epilepsy treatments: issues in preclinical methodology. Epilepsia 53 (2012), 571–582.
67. 67 McSweeney, KM, Gussow, AB, Bradrick, SS, et al. Inhibition of microRNA-128 promotes excitability of cultured cortical neuronal networks. Genome Res 26 (2016), 1411–1416.
68. 68 Conde, J, Artzi, N, Are RNAi and miRNA therapeutics truly dead?. Trends Biotechnol 33 (2015), 141–144.
69. 69 Bouchie, A, First microRNA mimic enters clinic. Nat Biotechnol, 31, 2013, 577.
70. 70 Janssen, HL, Reesink, HW, Lawitz, EJ, et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 368 (2013), 1685–1694.
71. 71 Miller, TM, Pestronk, A, David, W, et al. An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol 12 (2013), 435–442.
72. 72 van Gestel, MA, van Erp, S, Sanders, LE, et al. shRNA-induced saturation of the microRNA pathway in the rat brain. Gene Ther 21 (2014), 205–211.
73. 73 Chang, H, Yi, B, Ma, R, Zhang, X, Zhao, H, Xi, Y, CRISPR/cas9, a novel genomic tool to knock down microRNA in vitro and in vivo. Sci Rep, 6, 2016, 22312.
74. 74 Liu, DZ, Jickling, GC, Ander, BP, et al. Elevating microRNA-122 in blood improves outcomes after temporary middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 36 (2016), 1374–1383.
75. 75 van Scheppingen, J, Iyer, AM, Prabowo, AS, et al. Expression of microRNAs miR21, miR146a, and miR155 in tuberous sclerosis complex cortical tubers and their regulation in human astrocytes and SEGA-derived cell cultures. Glia 64 (2016), 1066–1082.